TY - JOUR
T1 - Breast Cancer Surgery in Veterans Affairs and Selected University Medical Centers
T2 - Results of the Patient Safety in Surgery Study
AU - Neumayer, Leigh
AU - Schifftner, Tracy L.
AU - Henderson, William G.
AU - Khuri, Shukri F.
AU - El-Tamer, Mahmoud
N1 - Funding Information:
This article is part of a group of articles from the Patient Safety in Surgery (PSS) Study, a demonstration project between the Department of Veterans Affairs’ National Surgical Quality Improvement Program (VA-NSQIP) and the American College of Surgeons (ACS) in selected private sector hospitals, and funded by the Agency for Healthcare Research and Quality (AHRQ), Grant Number 5U18HS011913, entitled Reporting System to Improve Patient Safety in Surgery. The PSS Study led to the successful formation of the American College of Surgeons’ National Surgical Quality Improvement Program (ACS-NSQIP). The opinions expressed are those of the authors and not necessarily those of the American College of Surgeons, the Department of Veterans Affairs, or the US government.
PY - 2007/6
Y1 - 2007/6
N2 - Background: Breast cancer is a common diagnosis. We compare perioperative characteristics and outcomes between male and female patients undergoing treatment for breast cancer and between hospital systems (Department of Veterans Affairs [VA] and private sector [PS]) as part of the Patient Safety in Surgery (PSS) Study. Study Design: We performed an analysis of a prospectively collected clinical database. Data collected from 128 VA hospitals and 14 PS academic medical centers as part of the Patient Safety in Surgery Study for fiscal years 2002 through 2004 were used. Analysis included calculation of crude and adjusted odds ratios for morbidity. Results: A total of 3,823 patients were included. Female VA patients at baseline had higher rates of smoking, steroid use, COPD, acute renal failure, dialysis, weight loss > 10%, preoperative chemotherapy, and abnormal laboratory values than female PS patients did. Male patients were older than the female patients in both hospital systems. Mortality rates were very low and similar among groups. All VA patients in this study had substantially longer lengths of stay than the patients in the PS. The unadjusted overall complication rate was 5.21%; the VA female patients experienced an unadjusted complication rate twice that of the PS female patients. When adjusted for confounding variables and differences in preoperative comorbidities, the odds ratio comparing VA with PS females was no longer markedly different (1.404; 95% CI, 0.894, 2.204). Conclusions: VA patients with breast cancer have higher incidences of most comorbidities than patients in the PS. Differences in complication rates females disappear when adjustment is made for the higher rates of comorbidities in the VA patients.
AB - Background: Breast cancer is a common diagnosis. We compare perioperative characteristics and outcomes between male and female patients undergoing treatment for breast cancer and between hospital systems (Department of Veterans Affairs [VA] and private sector [PS]) as part of the Patient Safety in Surgery (PSS) Study. Study Design: We performed an analysis of a prospectively collected clinical database. Data collected from 128 VA hospitals and 14 PS academic medical centers as part of the Patient Safety in Surgery Study for fiscal years 2002 through 2004 were used. Analysis included calculation of crude and adjusted odds ratios for morbidity. Results: A total of 3,823 patients were included. Female VA patients at baseline had higher rates of smoking, steroid use, COPD, acute renal failure, dialysis, weight loss > 10%, preoperative chemotherapy, and abnormal laboratory values than female PS patients did. Male patients were older than the female patients in both hospital systems. Mortality rates were very low and similar among groups. All VA patients in this study had substantially longer lengths of stay than the patients in the PS. The unadjusted overall complication rate was 5.21%; the VA female patients experienced an unadjusted complication rate twice that of the PS female patients. When adjusted for confounding variables and differences in preoperative comorbidities, the odds ratio comparing VA with PS females was no longer markedly different (1.404; 95% CI, 0.894, 2.204). Conclusions: VA patients with breast cancer have higher incidences of most comorbidities than patients in the PS. Differences in complication rates females disappear when adjustment is made for the higher rates of comorbidities in the VA patients.
UR - http://www.scopus.com/inward/record.url?scp=34249309578&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34249309578&partnerID=8YFLogxK
U2 - 10.1016/j.jamcollsurg.2007.03.018
DO - 10.1016/j.jamcollsurg.2007.03.018
M3 - Article
C2 - 17544081
AN - SCOPUS:34249309578
VL - 204
SP - 1235
EP - 1241
JO - Surgery Gynecology and Obstetrics
JF - Surgery Gynecology and Obstetrics
SN - 1072-7515
IS - 6
ER -